"Voriconazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.
Descriptor ID |
D065819
|
MeSH Number(s) |
D03.383.129.799.950
|
Concept/Terms |
UK 109,496- UK 109,496
- UK-109,496
- UK109,496
- UK-109496
- UK109496
- UK 109496
|
Below are MeSH descriptors whose meaning is more general than "Voriconazole".
Below are MeSH descriptors whose meaning is more specific than "Voriconazole".
This graph shows the total number of publications written about "Voriconazole" by people in this website by year, and whether "Voriconazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Voriconazole" by people in Profiles.
-
Magnitude of Voriconazole Resistance in Clinical and Environmental Isolates of Aspergillus flavus and Investigation into the Role of Multidrug Efflux Pumps. Antimicrob Agents Chemother. 2018 11; 62(11).
-
Voriconazole-induced hepatotoxicity following the administration of PEG-asparaginase: Case report. Pediatr Blood Cancer. 2017 06; 64(6).
-
Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report. Transpl Infect Dis. 2015 Feb; 17(1):94-7.
-
Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy. Clinics (Sao Paulo). 2012; 67(3):297-9.
-
Atypical Aspergillus flavus isolates associated with chronic azole therapy. J Clin Microbiol. 2009 Oct; 47(10):3372-5.
-
Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs. 2002 Mar; 11(3):409-29.